The treatment of Allergies & Caffeine Dependency with vitamins

Allergies and Caffeine Dependency: Mitamins custom make quality formulas for the treatment of Allergies & Caffeine Dependency with vitamins. A Allergies & Caffeine Dependency formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Caffeine Dependency

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Lactobacillus acidolphilus
    100
    mg
    *
    CoQ-10
    25
    mg
    *
    MSM
    100
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Asian Ginseng Extract
    100
    mg
    *
    Eleuthero Extract
    100
    mg
    *
  • Amount Per Serving
    % DV
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    L-Carnitine
    250
    mg
    *
    L-Tyrosine
    250
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    Ashwagandha Extract
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Allergies and Caffeine Dependency
Monthly Cost: $36.92
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Allergies and Caffeine Dependency Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Aranesp(R) Study Showing No Negative Impact On Survival In SCLC Presented At World Conference On Lung Cancer
Amgen (NASDAQ:AMGN) presented the results from a randomized, double-blind, placebo-controlled Phase 3 study evaluating the efficacy and safety of Aranesp(R) (darbepoetin alfa) in previously untreated patients with extensive-stage small-cell lung cancer (SCLC) receiving chemotherapy ("the 145 study") on Monday, Sept. 3 at the 2007 World Conference on Lung Cancer in Seoul, Korea.
New Analysis Of Data Shows Treatment With Abbott's HUMIRA® Significantly Reduced Disease-Related Hospitalization For Patients With Crohn's
Abbott today announced results from a post-hoc analysis of a pivotal study presented at the Digestive Disease Week annual meeting in Washington, D.C. showing patients with moderate to severely active Crohn's disease treated with HUMIRA® (adalimumab) maintenance therapy were almost 60 percent less likely than patients on placebo to be hospitalised due to their disease at one year (5.9 percent versus 13.9 percent; p
This information concerning the support of Allergies and Caffeine Dependency treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Allergies & Hey Fever  Allergies  Allergies and Caffeine Dependency
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments